InvestorsHub Logo
Followers 93
Posts 8868
Boards Moderated 0
Alias Born 05/06/2014

Re: KobeF post# 2308

Saturday, 05/16/2020 6:45:33 AM

Saturday, May 16, 2020 6:45:33 AM

Post# of 14947

If the Phase I trial starts by the beginning of July, they will know within a week or two whether the antibody is having an effect. If it is effective and safe in the patients, they would expect to start a larger Phase II trial in August or possibly September.

“Hopefully we will be able to submit for approval before the end of the year or beginning of next year,” Brunswick added.




“The pathway we’re following right now is quite similar to the pathways used in antibody therapies for oncology indications, where an antibody is discovered that is reactive to a specific cancer marker, grown up in culture, and given to patients,” Brunswick said. “So what we’ve done is identified an antibody that recognizes the COVID-19 virus and completely inhibits its binding to the specific receptor. This is grown up in vitro, in tissue culture, in cell fermenters.”


https://www.biospace.com/article/sorrento-ids-antibody-against-covid-19-that-appears-100-percent-effective/

Have they done any human trials yet? Or even pre-clinical animal trial yet? Or just the lab test results?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News